These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9681363)

  • 1. Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemia.
    Mansouri S; Dubertret L; Bastuji-Garin S; Dombret H; Roujeau JC; Aractingi S
    Arch Dermatol; 1998 Jul; 134(7):881-2. PubMed ID: 9681363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ambulatory period of treatment of adults with acute leukemia].
    Vinogradova IuE; Korovina VI
    Ter Arkh; 1981; 53(9):14-20. PubMed ID: 6458111
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
    Sternberg DW; Aird W; Neuberg D; Thompson L; MacNeill K; Amrein P; Shulman LN
    Cancer; 2000 May; 88(9):2037-41. PubMed ID: 10813714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatoses in patients with acute myeloid and lymphoid leukemia. Cohort follow-up in a tertiary care hospital].
    Sánchez-Hernández C; Crespo-Solís E; Rosas-López A; Archer-Dubon C; Orozco-Topete R
    Rev Invest Clin; 2011; 63(4):353-60. PubMed ID: 22364034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous reactions to STI571.
    Brouard M; Saurat JH
    N Engl J Med; 2001 Aug; 345(8):618-9. PubMed ID: 11529225
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of cutaneous reaction to chemotherapeutic agents showing epidermal dysmaturation.
    Chun YS; Chang SN; Oh D; Park WH
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):358-60. PubMed ID: 10901723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual manifestations of acute leukemia. Case 2. Leukemia and rash: paraneoplastic or drug-induced?
    Blank C; Wagner HM; Hohenleutner U; Andreesen R
    J Clin Oncol; 2000 Oct; 18(19):3437-9. PubMed ID: 11013285
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia.
    Brouard MC; Prins C; Mach-Pascual S; Saurat JH
    Dermatology; 2001; 203(1):57-9. PubMed ID: 11549802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men.
    Russell JA; Powles RL; Oliver RT
    Br Med J; 1976 Jun; 1(6024):1508. PubMed ID: 1064461
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia.
    Shi CR; Nambudiri VE
    Am J Hematol; 2018 Mar; 93(3):467-468. PubMed ID: 28836284
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I study of pyrazofurin in refractory acute myelogenous leukemia.
    Vogler WR; Trulock PD
    Cancer Treat Rep; 1978 Oct; 62(10):1569-71. PubMed ID: 152146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
    Scott AD; Lee M; Kubba F; Chu A
    Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
    [No Abstract]   [Full Text] [Related]  

  • 13. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P; Das NK; Sil A; Chakrabarti P
    J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in chemotherapy of acute leukemia].
    Prandota J
    Postepy Hig Med Dosw; 1974 Mar; 28(2):193-228. PubMed ID: 4526037
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive chemotherapy for acute myelogenous leukemia.
    Gale RP; Foon KA; Cline MJ; Zighelboim J
    Ann Intern Med; 1981 Jun; 94(6):753-7. PubMed ID: 6940466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib: a designer drug, another cutaneous complication.
    Dickens E; Lewis F; Bienz N
    Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia].
    Usui N
    Rinsho Ketsueki; 2007 Jun; 48(6):458-67. PubMed ID: 17633093
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy-induced recall dermatitis on a previously scalded wound in a patient with acute myeloid leukaemia.
    Chu CY; Chiu HC
    Acta Derm Venereol; 2003; 83(5):382-3. PubMed ID: 14609113
    [No Abstract]   [Full Text] [Related]  

  • 19. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
    Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
    Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
    Dervis E; Ayer M; Akin Belli A; Barut SG
    Eur J Dermatol; 2016 Apr; 26(2):133-7. PubMed ID: 26679005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.